Clinical Trial Update: A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 PET imaging study of SLV354 in healthy subjects and individuals with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SLV354

Snippet

Sponsor: Abbott | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED